HARVARD BIOSCIENCE INC

HBIO

HARVARD BIOSCIENCE INC

HBIO

Insider Sentiment (TTM):

Last Purchase:2026-03-17Last Sale:-Shares Purchased (TTM):28,475Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:1,401,500Shares Outstanding:4,473,000Institutional Ownership Pct.:31.33%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets Current
Cash And Cash Equivalents At Carrying Value	7	7	9	7	7	6	4	5	4	4	4	5
Accounts Receivable Net Current	15	15	16	12	12	13	15	13	12	15	16	15
Inventory Net	22	22	21	22	22	23	23	26	25	24	25	26
Other Assets Current	3	4	3	3	3	3	3	3	5	4	4	4
Assets Current	46	47	48	44	45	45	45	47	46	48	49	50
Property Plant And Equipment Net	5	5	5	5	5	5	5	5	5	4	4	3
Operating Lease Right Of Use Asset	6	7	7	8	7	7	6	7	4	4	5	5
Goodwill	9	9	10	10	10	9	56	57	57	57	57	56
Intangible Assets Net Excluding Goodwill	6	7	8	8	9	10	11	12	13	15	16	17
Other Assets Noncurrent	3	3	3	4	4	4	3	3	3	5	6	8
Assets	76	78	80	78	80	80	127	131	129	133	137	140
Liabilities Current
Secured Debt Current	-	-	0	34	35	36	37	4	4	4	6	3
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	1	1	2
Accounts Payable Current	6	5	4	5	5	5	5	5	6	6	6	6
Contract With Customer Liability Current	4	4	3	3	3	3	4	4	4	4	5	4
Other Liabilities Current	15	15	15	12	12	11	9	10	9	10	11	8
Liabilities Current	25	24	22	54	55	56	55	23	23	26	27	24
Long Term Debt Noncurrent	37	36	36	-	-	-	0	34	32	32	31	35
Deferred Income Tax Liabilities Net	0	0	0	1	1	1	1	1	1	1	1	1
Operating Lease Liability Noncurrent	6	6	7	7	7	7	6	7	5	5	5	4
Other Liabilities Noncurrent	1	1	1	1	1	1	1	2	2	1	1	1
Liabilities	69	68	66	64	64	65	63	66	62	64	64	65
Preferred Stock Value	-	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	240	240	240	238	238	237	237	236	235	233	232	233
Retained Earnings Accumulated Deficit	-221	-218	-215	-212	-211	-208	-158	-158	-153	-150	-146	-144
Accumulated Other Comprehensive Income Loss Net Of…	-12	-12	-12	-12	-12	-14	-16	-13	-15	-15	-14	-15
Stockholders Equity	7	10	14	14	16	15	63	65	67	69	73	74
Liabilities And Stockholders Equity	76	78	80	78	80	80	127	131	129	133	137	140
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	-	-	-	-	-
Preferred Stock No Par Value	-	-	-	-	-	-	0	0	0	0	0	0
Preferred Stock Shares Authorized	5	5	5	5	5	5	5	5	5	5	5	5
Common Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Common Stock Shares Authorized	80	80	80	80	80	80	80	80	80	80	80	80
Common Stock Shares Issued	5	5	4	4	4	4	4	4	4	4	4	4
Shares Outstanding	5	45	4	4	4	4	4	4	4	4	4	4

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	14.60%	13.68%	12.57%	-	-	-	-	-	-	-	-	-
2025	17.14%	28.57%	25.71%	0.00%	-6.25%	8.33%	38.18%	27.27%	7.27%	10.64%	35.32%	25.11%
2024	-15.47%	-24.00%	-12.00%	-7.69%	-12.82%	-25.64%	-14.40%	-22.96%	-32.30%	-38.46%	-46.15%	-27.69%
2023	-	-	-	-	-	-	3.53%	25.88%	7.29%	-5.99%	-19.73%	-29.93%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	1.87	1.99	2.20	0.81	0.81	0.81	0.82	2.06	2.05	1.88	1.85	2.09
Quick Ratio	0.98	1.06	1.25	0.41	0.41	0.40	0.40	0.91	0.94	0.94	0.92	1.02
Working Capital	21.67M	23.62M	26.27M	-10.59M	-10.23M	-10.70M	-9.84M	24.04M	23.81M	22.47M	22.50M	26.28M
Leverage & Debt
Debt to Equity	9.28	6.76	4.83	4.54	4.09	4.38	1.00	1.01	0.92	0.94	0.88	0.88
Interest Coverage TTM	-0.04	-0.02	-9.88	-12.32	-13.19	-14.42	-1.76	-1.89	-1.57	-0.63	0.53	-3.32
Debt Ratio	0.90	0.87	0.83	0.82	0.80	0.81	0.50	0.50	0.48	0.48	0.47	0.47
Efficiency & Turnover
Asset Turnover TTM	1.12	1.08	0.84	0.84	0.85	0.86	0.71	0.72	0.74	0.77	0.79	0.78
Days Sales Outstanding TTM	54.95	59.85	65.17	52.09	50.22	57.48	60.03	51.94	53.04	56.48	53.33	48.67
Receivables Turnover TTM	6.64	6.10	5.60	7.01	7.27	6.35	6.08	7.03	6.88	6.46	6.84	7.50
Per Share Metrics
Diluted EPS TTM	-	-	-	-	-	-	-	-	-	-2.01	-	-
Free Cash Flow Per Share TTM	-0.25	0.43	1.23	1.67	1.09	0.12	-0.28	0.19	1.54	2.63	2.89	2.63
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	58.16%	58.42%	57.67%	56.94%	56.89%	57.09%	58.18%	58.40%	58.39%	58.52%	58.86%	58.28%
Operating Profit Margin TTM	-0.28%	-0.10%	-56.13%	-57.55%	-58.99%	-58.65%	-6.60%	-6.08%	-4.94%	-2.00%	1.69%	-10.90%
Net Profit Margin TTM	-11.86%	-11.44%	-65.51%	-61.62%	-64.68%	-63.52%	-13.18%	-14.57%	-10.56%	-8.18%	-3.04%	-2.90%
Growth Metrics
Net Revenue Growth (1Y)	-1.06%	-6.42%	-8.06%	-10.60%	-12.24%	-14.41%	-16.14%	-13.15%	-11.36%	-6.76%	-0.96%	-4.61%
Net Income Growth (1Y)	-81.86%	-83.15%	357.07%	278.03%	437.61%	564.88%	263.25%	336.44%	96.68%	333.52%	-64.11%	-52.63%
EPS Growth (1Y)	-82.25%	-83.38%	348.29%	270.04%	427.73%	554.36%	253.92%	327.17%	91.56%	320.70%	-64.96%	-53.80%
Valuation Metrics
P/E TTM	-2.67	-2.23	-0.52	-0.36	-0.34	-0.43	-7.41	-8.24	-11.61	-21.08	-66.46	-56.25
P/B TTM	3.75	2.17	2.17	1.39	1.24	1.69	1.45	1.80	1.84	2.67	3.11	2.47
P/S TTM	0.32	0.25	0.34	0.22	0.22	0.28	0.98	1.20	1.23	1.72	2.02	1.63
Market Cap	27.83M	21.78M	29.74M	19.60M	19.49M	25.14M	91.87M	117.32M	123.94M	184.02M	226.95M	183.56M
Enterprise Value	58.01M	50.90M	57.00M	46.75M	46.91M	55.55M	124.71M	150.61M	155.57M	215.38M	259.23M	216.96M
Calculated Values
Free Cash Flow TTM	-1.12M	1.91M	5.47M	7.44M	4.84M	511.00K	-1.20M	845.00K	6.71M	11.41M	12.24M	11.21M
Net Debt	30.18M	29.11M	27.26M	27.15M	27.42M	30.41M	32.85M	33.29M	31.63M	31.36M	32.28M	33.40M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-17Purchase

Owner: Denelsky, Stephen J

Title: -

Shares: 10,000

Price/Share: $4.87

Value: $48,700.00

Shares Owned: 21,000

Relationship: Director

Ownership: Direct

2026-03-17Purchase

Owner: Snider, William

Title: -

Shares: 8,475

Price/Share: $4.85

Value: $41,103.75

Shares Owned: 32,000

Relationship: Director

Ownership: Direct

2026-03-16Purchase

Owner: Duke, John D

Title: Chief Executive Officer

Shares: 5,000

Price/Share: $5.01

Value: $25,050.00

Shares Owned: 105,000

Relationship: Director,Officer

Ownership: Direct

2026-03-16Purchase

Owner: Frost, Mark T

Title: Chief Financial Officer

Shares: 5,000

Price/Share: $5.00

Value: $25,000.00

Shares Owned: 17,500

Relationship: Officer

Ownership: Direct

2024-06-13Purchase

Owner: Green, James W

Title: Chief Executive Officer

Shares: 10,000

Price/Share: $2.91

Value: $29,100.00

Shares Owned: 3,111,091

Relationship: Director,Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-17	Denelsky, Stephen J	Director	-	Direct	Purchase	10,000	4.87	$48,700.00	21,000	4
2026-03-17	Snider, William	Director	-	Direct	Purchase	8,475	4.85	$41,103.75	32,000	4
2026-03-16	Duke, John D	Director,Officer	Chief Executive Officer	Direct	Purchase	5,000	5.01	$25,050.00	105,000	4
2026-03-16	Frost, Mark T	Officer	Chief Financial Officer	Direct	Purchase	5,000	5.00	$25,000.00	17,500	4
2024-06-13	Green, James W	Director,Officer	Chief Executive Officer	Direct	Purchase	10,000	2.91	$29,100.00	3,111,091	4
2024-06-06	Green, James W	Director,Officer	Chief Executive Officer	Direct	Purchase	20,000	3.07	$61,400.00	3,101,091	4
2023-08-17	Green, James W	Director,Officer	Chief Executive Officer	Direct	Purchase	25,000	4.38	$109,500.00	2,862,679	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

31.33%

Inst. Shares: 1,401,500

Shares Outstanding: 4,473,000

2025-12-31

35.21%

Inst. Shares: 15,628,614

Shares Outstanding: 44,391,000

2025-09-30

34.91%

Inst. Shares: 15,553,973

Shares Outstanding: 44,556,000

2025-06-30

40.13%

Inst. Shares: 17,778,668

Shares Outstanding: 44,303,000

2025-03-31

Inst. Shares: 24,294,880

Shares Outstanding: 4,410,000

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	1,401,500	4,473,000	31.33%
2025-12-31	15,628,614	44,391,000	35.21%
2025-09-30	15,553,973	44,556,000	34.91%
2025-06-30	17,778,668	44,303,000	40.13%
2025-03-31	24,294,880	4,410,000	-
2024-12-31	29,671,734	43,538,000	68.15%
2024-09-30	29,342,016	43,614,000	67.28%
2024-06-30	30,752,330	43,486,000	70.72%
2024-03-31	30,455,657	43,402,000	70.17%
2023-12-31	27,787,699	42,420,000	65.51%
2023-09-30	30,672,993	42,688,000	71.85%
2023-06-30	30,106,527	42,354,000	71.08%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

HARVARD BIOSCIENCE INC (HBIO) — SEC Financial Statements & Analysis

HARVARD BIOSCIENCE INC (HBIO) is a laboratory analytical instruments company, incorporated in DE. HARVARD BIOSCIENCE INC trades on Nasdaq as: HBIO. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), HARVARD BIOSCIENCE INC reported a -1.06% year-over-year revenue growth, a Gross Profit Margin of 58.16% (TTM), a Debt-to-Equity ratio of 9.28x, a Price-to-Sales (P/S) ratio of 0.32x (TTM), a Price-to-Book (P/B) ratio of 3.75x (TTM), at a market cap of $27.83M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -1.06%
Gross Profit Margin TTM: 58.16%
Debt To Equity: 9.28x
P/S TTM: 0.32x
P/B TTM: 3.75x
Market Cap: $27.83M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is HARVARD BIOSCIENCE INC in?

HARVARD BIOSCIENCE INC (HBIO) operates in the Laboratory Analytical Instruments industry.

What is HBIO's market cap?

HARVARD BIOSCIENCE INC (HBIO) has a market capitalization of $27.83M as of 2026-06-30.

What exchange does HBIO trade on?

HARVARD BIOSCIENCE INC (HBIO) trades on the Nasdaq.

Where is HARVARD BIOSCIENCE INC incorporated?

HARVARD BIOSCIENCE INC is incorporated in DE.